FI844678L - Hoegeligen renat protein, dess framstaellning och anvaendning. - Google Patents

Hoegeligen renat protein, dess framstaellning och anvaendning.

Info

Publication number
FI844678L
FI844678L FI844678A FI844678A FI844678L FI 844678 L FI844678 L FI 844678L FI 844678 A FI844678 A FI 844678A FI 844678 A FI844678 A FI 844678A FI 844678 L FI844678 L FI 844678L
Authority
FI
Finland
Prior art keywords
ring
procedure
processing
processing ring
procedure ring
Prior art date
Application number
FI844678A
Other languages
English (en)
Other versions
FI81118B (fi
FI844678A0 (fi
FI81118C (fi
Inventor
Koichi Kato
Takao Yamada
Haruo Onda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16823684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI844678(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI844678A0 publication Critical patent/FI844678A0/fi
Publication of FI844678L publication Critical patent/FI844678L/fi
Publication of FI81118B publication Critical patent/FI81118B/fi
Application granted granted Critical
Publication of FI81118C publication Critical patent/FI81118C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/55IL-2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI844678A 1983-11-28 1984-11-28 Foerfarande foer framstaellning av vaesentligen rent interleukin-2 protein. FI81118C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58225079A JPS60115528A (ja) 1983-11-28 1983-11-28 ヒトインタ―ロイキン―2蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
JP22507983 1983-11-28

Publications (4)

Publication Number Publication Date
FI844678A0 FI844678A0 (fi) 1984-11-28
FI844678L true FI844678L (fi) 1985-05-29
FI81118B FI81118B (fi) 1990-05-31
FI81118C FI81118C (fi) 1990-09-10

Family

ID=16823684

Family Applications (1)

Application Number Title Priority Date Filing Date
FI844678A FI81118C (fi) 1983-11-28 1984-11-28 Foerfarande foer framstaellning av vaesentligen rent interleukin-2 protein.

Country Status (16)

Country Link
US (1) US5464939A (fi)
EP (3) EP0442538A1 (fi)
JP (1) JPS60115528A (fi)
KR (1) KR920006879B1 (fi)
DK (1) DK164174C (fi)
ES (1) ES8606489A1 (fi)
FI (1) FI81118C (fi)
GR (1) GR81040B (fi)
HU (1) HU200793B (fi)
IL (1) IL73530A0 (fi)
MY (1) MY103892A (fi)
NO (1) NO169021C (fi)
NZ (1) NZ210352A (fi)
PT (1) PT79555B (fi)
SG (1) SG46452A1 (fi)
ZA (1) ZA849221B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
DK174501B1 (da) * 1983-12-23 2003-04-28 Hoffmann La Roche Fremgangsmåde til fremstilling af interleukin-2
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
JPS60243021A (ja) * 1984-03-28 1985-12-03 シタス コ−ポレイシヨン システイン含有蛋白質の制御された酸化方法
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
WO1986002068A1 (en) * 1984-09-26 1986-04-10 Takeda Chemical Industries, Ltd. Mutual separation of proteins
JPH0646957B2 (ja) * 1985-03-11 1994-06-22 武田薬品工業株式会社 インタ−ロイキン−2の製造方法
WO1986007093A1 (en) * 1985-05-29 1986-12-04 The Green Cross Corporation Process for preparing heterogenic protein
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
DE3581412D1 (de) * 1985-07-16 1991-02-21 Green Cross Corp Verfahren zur herstellung von heteroproteinen.
DE3526096A1 (de) * 1985-07-22 1987-01-22 Basf Ag Verfahren zur reinigung von htnf
CN86104525A (zh) * 1985-07-31 1987-02-25 武田药品工业株式会社 人类白细胞介素-2的分析方法和试剂
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf
US4933433A (en) * 1986-01-31 1990-06-12 E. I. Du Pont De Nemours And Company Recombinant interleukin-2 composition and process for making it
JPH0655153B2 (ja) * 1986-02-26 1994-07-27 武田薬品工業株式会社 ヒトインターロイキン―2結晶の製造法
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5149788A (en) * 1987-05-19 1992-09-22 Hoffmann-La Roche, Inc. Purification of chimeric proteins containing an IL-2 moiety by receptor-affinity chromatography
US5162503A (en) * 1987-05-19 1992-11-10 Hoffmann-La Roche, Inc. Purification of interleukin-2 by receptor-affinity chromatography
FR2635527B1 (fr) * 1988-07-28 1992-06-12 Roussel Uclaf Il2 humaine recombinante non glycosylee sous forme reduite, son procede d'obtention et son application comme medicament
US5250296A (en) * 1990-11-29 1993-10-05 Takeda Chemical Industries, Ltd. Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
US5416071A (en) * 1991-03-12 1995-05-16 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release containing epo and hyaluronic acid
CA2471363C (en) 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
GB201000693D0 (en) 2010-01-15 2010-03-03 Isis Innovation A solar cell
WO2012065086A1 (en) * 2010-11-12 2012-05-18 Nektar Therapeutics Conjugates of an il-2 moiety and a polymer
EP3204119B1 (en) 2014-10-09 2021-06-09 Dana-Farber Cancer Institute, Inc. Multiple-variable il-2 dose regimen for treating immune disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58116498A (ja) * 1981-12-28 1983-07-11 Takeda Chem Ind Ltd Il‐2をコードする新規伝令rnaの製造法
JPH0751511B2 (ja) * 1982-03-15 1995-06-05 味の素株式会社 インターロイキン2を含有してなる癌治療剤
CA1210714A (en) * 1982-03-23 1986-09-02 Alan Sloma .alpha.-INTERFERON GX-1
US4738927A (en) * 1982-03-31 1988-04-19 Ajinomoto Co. Inc. Gene coded for interleukin-2 polypeptide, recombinant DNA carrying the said gene, a living cell line possessing the recombinant DNA, and method for producing interleukin-2 using the said cell
JPS58201979A (ja) * 1982-05-18 1983-11-25 Japan Found Cancer ヒトインタ−ロイキン2遺伝子が組込まれているエシエリヒア・コリおよびその育種方法
CA1341562C (en) * 1982-03-31 2007-11-27 Tadatsugu Taniguchi Gene coded for interleukin-2 polypeptide, recombinant dna carrying the said gene, a living cell line possessing the recombinant dna, and method for producing interleukin-2 using the said cell
JPS58168492A (ja) * 1982-03-31 1983-10-04 Nippon Kokan Kk <Nkk> パイプ切断機
DE3378128D1 (en) * 1982-04-20 1988-11-03 Sloan Kettering Inst Cancer Purification of interleukin 2
JPS58198293A (ja) * 1982-05-12 1983-11-18 Shionogi & Co Ltd インタ−ロイキン等免疫調節因子の製造方法
NL8203321A (nl) * 1982-08-25 1984-03-16 Philips Nv Kleurenbeeldbuis.
US4490289A (en) * 1982-09-16 1984-12-25 Hoffmann-La Roche Inc. Homogeneous human interleukin 2
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
IL71275A0 (en) * 1983-03-21 1984-06-29 Sparamedica Ag Human interleukin-2-and its preparation
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
JPS61500586A (ja) * 1983-11-14 1986-04-03 チロン コ−ポレイシヨン インタ−ロイキン−2産生のための方法及び組成物
DK174501B1 (da) * 1983-12-23 2003-04-28 Hoffmann La Roche Fremgangsmåde til fremstilling af interleukin-2
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
JP2608730B2 (ja) * 1987-08-10 1997-05-14 株式会社リコー 感熱記録材料

Also Published As

Publication number Publication date
ZA849221B (en) 1986-07-30
JPS60115528A (ja) 1985-06-22
AU3575684A (en) 1985-06-06
ES537994A0 (es) 1986-04-01
KR920006879B1 (ko) 1992-08-21
DK560784A (da) 1985-05-29
FI81118B (fi) 1990-05-31
DK164174C (da) 1992-10-05
US5464939A (en) 1995-11-07
NO169021B (no) 1992-01-20
MY103892A (en) 1993-10-30
HUT36186A (en) 1985-08-28
NZ210352A (en) 1988-11-29
DK164174B (da) 1992-05-18
AU592527B2 (en) 1990-01-18
FI844678A0 (fi) 1984-11-28
PT79555B (en) 1986-12-15
SG46452A1 (en) 1998-02-20
GR81040B (en) 1985-03-27
DK560784D0 (da) 1984-11-27
IL73530A0 (en) 1985-02-28
NO169021C (no) 1992-04-29
FI81118C (fi) 1990-09-10
PT79555A (en) 1984-12-01
HU200793B (en) 1990-08-28
EP0145390A3 (en) 1987-01-21
EP0751220A1 (en) 1997-01-02
EP0442538A1 (en) 1991-08-21
JPH0542413B2 (fi) 1993-06-28
EP0145390A2 (en) 1985-06-19
KR850003734A (ko) 1985-06-26
NO844710L (no) 1985-05-29
ES8606489A1 (es) 1986-04-01

Similar Documents

Publication Publication Date Title
FI844678L (fi) Hoegeligen renat protein, dess framstaellning och anvaendning.
FI842916A0 (fi) Ny eldfast glykoamylas och dess framstaellningsfoerfarande.
FI843620A0 (fi) 6-fluor-1,4-dihydro-4-oxo-7- substituerad piperazinyl-kinolin-3-karboxylsyraderivat och foerfarande foer dess framstaellning.
FI843594L (fi) Trihalogenmetylgrupper innehaollande karbonylmetylenheterocykler, foerfarande foer deras framstaellning och ljuskaenslig blandning vilken innehaoller dessa foereningar.
FI845038A0 (fi) Vattenloeslig, aminerad -1,3-bunden d-glukan och komposition innehaollande densamma.
FI843856L (fi) 1-benzyl-aminoalkyl-pyrrolidinoner och deras syraadditionssalter, foerfarande foer deras framstaellning och laekemedel.
FI841128A (fi) Pyrimidinderivat, deras framstaellning och deras anvaendning.
FI842459A0 (fi) Tetrahydropyridazinonderivat, foerfaranden foer deras framstaellning och deras anvaendning.
FI841841A0 (fi) 1-pyrimidinyloxi-3-hetarylalkylamino-2- propanoler, deras framstaellning och anvaendning.
FI844889L (fi) Foernaetade polymerater, foerfarande foer deras framstaellning och deras anvaendning.
FI840206A (fi) Aminosyraderivat, foerfarande foer deras framstaellning och anvaendning.
FI840428A (fi) Biologiskt aktivt ketonderivat, framstaellning och anvaendning.
FI873519A0 (fi) Krackningskatalysator, dess framstaellning och anvaendning.
FI833469A (fi) Bandblockplanta, foerfarande och anordning foer dess uppdragning och plantering.
FI874756A0 (fi) Plastroer, foerfarande och anordning foer dess framstaellning.
FI842210A (fi) Kefalosporinester-derivat, deras framstaellning och anvaendning.
FI841615A (fi) 4-fenyl-tetrahydro-furano-pyridiner, foerfarande foer deras framstaellning och farmaceutiska blandningar.
FI843825L (fi) Faergkatodstraolroer, komponent och framstaellningsmetod.
FI844002L (fi) Stabiliserade, inerta organiska vaetskor innehaollande natriumditionitprodukter och deras anvaendning.
FI843824A0 (fi) Faergkatodstraolroer, komponent och framstaellningsmetod.
FI844572A0 (fi) Bensaldehydderivat och process foer dess framstaellning.
FI841412A0 (fi) Laett klyvbart, sjaelvtexturerande sammansatt garn.
FI862291A0 (fi) Eps-kombinationsskumstycke, foerfarande foer dess framstaellning och dess anvaendning.
FI842300A (fi) Mono- och ditioestrar, deras framstaellning och anvaendning.
FI77941B (fi) Reagens foer bestaemning av glukos, kolesterol, urinsyra och hemoglobin.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: TAKEDA CHEMICAL INDUSTRIES, LTD.